Completed PHASE4 INTERVENTIONAL 2-arm NCT02602704

Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients

Sponsor: Hanyang University

Interventions Bazedoxifene Calcium/Vit D

Updated 9 times since 2017 Last updated: Aug 10, 2020 Started: Dec 29, 2015 Primary completion: Oct 11, 2017 Completion: Dec 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Arthritis, Rheumatoid and is currently completed. Hanyang University leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Sep 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 4 earlier versions

Mar 2020 — Sep 2020 [monthly]

Unknown Status PHASE4

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Mar 2020 [monthly]

Active Not Recruiting PHASE4
Mar 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting
Jan 2017 — Mar 2018 [monthly]

Recruiting PHASE4

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hanyang University
Pfizer

Data source: Hanyang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea